Evaluation and modifcation of lung immune prognostic index in patients with metastatic NSCLC treated by immunotherapy

Aim of the study: to evaluate prognostic value of baseline lung immune prognostic index (LIPI) and its modification (mLIPI) for metastatic non-small cell lung cancer (mNSCLC) patients treated with immune checkpoint inhibitors (ICI).Material and methods. Baseline neutrophil-to-lymphocyte ratio, lacta...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, T. D. Barbolina, I. A. Djanyan
Format:	Artigo
Sprog:	Russo
Udgivet:	Russian Academy of Sciences, Tomsk National Research Medical Center 2023-05-01
Serier:	Сибирский онкологический журнал
Fag:	nsclc prognostic factors immunotherapy lung immune prognostic index lipi.
Online adgang:	https://www.siboncoj.ru/jour/article/view/2529
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!